Immunophotonics, Inc., a clinical-stage biotech company focused on developing novel Immune-stimulating drugs to augment routine tumor destruction techniques, has announced the appointment of Richard Levenson, M.D. to its Board of Directors.Dr. Levenson further strengthens the company’s Board of Directors with
Cousins Matthew and Christopher Callero join Cetera to access expanded growth resources and support their expansion plans Cetera is pleased to announce that veteran advisors Matthew Callero, CRPC®, and Christopher Callero, CFP®, have joined Cetera Financial Specialists within Cetera’s Tax
HCLTech, a leading global technology company, announced that it has signed a strategic collaboration agreement with Amazon Web Services (AWS) to accelerate innovation in the financial services industry through autonomous, AI-powered solutions. The collaboration brings together HCLTech’s deep domain expertise
Brought to you by
Copyright © 2026 SalesTechStar. All Rights Reserved. Website Design: SalesTechStar | Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
